Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

VALERIE DIANE ESPINOSA

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1649245697
CMS profile
120305
Location
AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$180.01

9 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $180.01 9

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Novo Nordisk Inc $35.78 2
Medtronic, Inc. $34.64 2
Nevro Corp. $33.71 1
Lilly USA, LLC $22.85 1
AbbVie Inc. $19.84 1
RECORDATI_RARE_DISEASES_INC. $18.99 1
Xeris Pharmaceuticals, Inc. $14.20 1

Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

VALERIE DIANE ESPINOSA

NPI 1649245697 · CMS profile ID 120305

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

AUSTIN, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1649245697?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
VALERIE DIANE ESPINOSA, NPI 1649245697, CMS profile ID 120305. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1649245697?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). VALERIE DIANE ESPINOSA, NPI 1649245697, CMS profile ID 120305. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1649245697?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
VALERIE DIANE ESPINOSA, NPI 1649245697, CMS profile ID 120305, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1649245697?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

9 matching records · $180.01 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 9 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–9 of 9.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novo Nordisk Inc $16.0512/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811603911 CMS
AbbVie Inc. $19.8412/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794417113 CMS
Medtronic, Inc. $23.1511/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827243013 CMS
RECORDATI_RARE_DISEASES_INC. $18.9911/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831402491 CMS
Lilly USA, LLC $22.8511/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818780141 CMS
Nevro Corp. $33.7107/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832295583 CMS
Novo Nordisk Inc $19.7306/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810784899 CMS
Xeris Pharmaceuticals, Inc. $14.2005/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837420748 CMS
Medtronic, Inc. $11.4905/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815755858 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $16.77 1
PY2020 $2,295.00 1
PY2021 $180.01 9
PY2022 $102.32 6
PY2023 $158.18 9
PY2024 $80.44 4
PY2025 $190.15 9

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $6,754.50 7
PY2024 Principal investigator $16,033.58 16
PY2023 Principal investigator $23,025.89 42
PY2022 Recipient $4,540.00 1
PY2022 Principal investigator $427,933.76 272
PY2021 Principal investigator $331,661.14 458
PY2020 Principal investigator $107,369.32 113
PY2019 Principal investigator $258,474.85 102

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

458 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $27.41 12/30/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948723
Principal investigator 1 Novo Nordisk AS $27.41 12/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739275
Principal investigator 1 Novo Nordisk AS $422.15 12/23/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767339
Principal investigator 1 Novo Nordisk AS $30,207.64 12/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948747
Principal investigator 1 Novo Nordisk AS $100.00 12/22/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739287
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,200.00 12/09/2021 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY PA
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 816783587
Principal investigator 1 Novo Nordisk AS $750.00 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767337
Principal investigator 1 Novo Nordisk AS $937.50 12/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811817877
Principal investigator 1 Novo Nordisk AS $25.06 11/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767333
Principal investigator 1 Novo Nordisk AS $27.41 11/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208537
Principal investigator 1 Novo Nordisk AS $27.41 11/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739271
Principal investigator 1 Novo Nordisk AS $27.41 11/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805213
Principal investigator 1 Novo Nordisk AS $8,114.94 11/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948737
Principal investigator 1 Novo Nordisk AS $27.41 11/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805209
Principal investigator 1 Novo Nordisk AS $27.41 11/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805211
Principal investigator 1 Novo Nordisk AS $27.41 11/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948709
Principal investigator 1 Novo Nordisk AS $4,950.00 11/11/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 833636195
Principal investigator 1 Novo Nordisk AS $5,280.00 11/11/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 833636197
Principal investigator 1 Novo Nordisk AS $5,280.00 11/11/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 833636199
Principal investigator 1 Novo Nordisk AS $5,280.00 11/11/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 833636201
Principal investigator 1 Novo Nordisk AS $4,950.00 11/11/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 833636203
Principal investigator 1 Novo Nordisk AS $5,280.00 11/11/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 833636205
Principal investigator 1 Novo Nordisk AS $5,280.00 11/11/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 833636207
Principal investigator 1 Novo Nordisk AS $5,280.00 11/11/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 833636209
Principal investigator 1 Novo Nordisk AS $594.00 11/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739259
Principal investigator 1 Novo Nordisk AS $658.80 11/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739265
Principal investigator 1 Novo Nordisk AS $27.41 11/04/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739489
Principal investigator 1 Novo Nordisk AS $27.41 11/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208527
Principal investigator 1 Novo Nordisk AS $1,188.00 11/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208835
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $600.00 10/30/2021 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY PA
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 816772675
Principal investigator 1 Novo Nordisk AS $10,761.52 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739281
Principal investigator 1 Novo Nordisk AS $422.15 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811817875
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $600.00 10/27/2021 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY PA
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 816772239
Principal investigator 1 Novo Nordisk AS $27.41 10/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805287
Principal investigator 1 Novo Nordisk AS $23.06 10/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984417
Principal investigator 1 Novo Nordisk AS $27.41 10/13/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208825
Principal investigator 1 Novo Nordisk AS $27.41 10/04/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949273
Principal investigator 1 Novo Nordisk AS $27.41 10/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949287
Principal investigator 1 Novo Nordisk AS $27.41 10/01/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739483
Principal investigator 1 Novo Nordisk AS $27.21 09/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948641
Principal investigator 1 Novo Nordisk AS $325.80 09/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810955173
Principal investigator 1 Novo Nordisk AS $836.72 09/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767335
Principal investigator 1 Novo Nordisk AS $9,505.43 09/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805215
Principal investigator 1 Novo Nordisk AS $5,940.00 08/31/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948655
Principal investigator 1 Novo Nordisk AS $4.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948669
Principal investigator 1 Novo Nordisk AS $4.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948683
Principal investigator 1 Novo Nordisk AS $4.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948697
Principal investigator 1 Novo Nordisk AS $4.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949259
Principal investigator 1 Novo Nordisk AS $40.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208509
Principal investigator 1 Novo Nordisk AS $4.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208517
Principal investigator 1 Novo Nordisk AS $9.74 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208691
Principal investigator 1 Novo Nordisk AS $4.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208785
Principal investigator 1 Novo Nordisk AS $19.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208795
Principal investigator 1 Novo Nordisk AS $2.92 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208805
Principal investigator 1 Novo Nordisk AS $11.40 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208815
Principal investigator 1 Novo Nordisk AS $40.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739235
Principal investigator 1 Novo Nordisk AS $40.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739241
Principal investigator 1 Novo Nordisk AS $40.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739247
Principal investigator 1 Novo Nordisk AS $4.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739253
Principal investigator 1 Novo Nordisk AS $0.64 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739341
Principal investigator 1 Novo Nordisk AS $39.90 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739347
Principal investigator 1 Novo Nordisk AS $6.50 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739353
Principal investigator 1 Novo Nordisk AS $3.26 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739471
Principal investigator 1 Novo Nordisk AS $40.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805199
Principal investigator 1 Novo Nordisk AS $40.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805201
Principal investigator 1 Novo Nordisk AS $40.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805203
Principal investigator 1 Novo Nordisk AS $40.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805205
Principal investigator 1 Novo Nordisk AS $4.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805207
Principal investigator 1 Novo Nordisk AS $40.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805245
Principal investigator 1 Novo Nordisk AS $394.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805283
Principal investigator 1 Novo Nordisk AS $8.00 08/27/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805285
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984309
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984323
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984335
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984349
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984363
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984377
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984391
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984429
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984443
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811248574
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811248583
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811248593
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811248603
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811248613
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767321
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767323
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767325
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767327
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767329
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767331
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767341
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811817869
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811817871
Principal investigator 1 Novo Nordisk AS $29.94 08/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811817873
Principal investigator 1 Novo Nordisk AS $13,364.52 08/25/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739365
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $900.00 08/19/2021 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY PA
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 816754353
Principal investigator 1 Novo Nordisk AS $27.21 08/05/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949247
Principal investigator 1 Novo Nordisk AS $27.21 08/04/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810955187
Principal investigator 1 Novo Nordisk AS $414.57 07/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811248623
Principal investigator 1 Novo Nordisk AS $7,177.50 07/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739359
Principal investigator 1 Novo Nordisk AS $23.06 07/20/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811817867
Principal investigator 1 Novo Nordisk AS $2,970.00 07/19/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805197
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948283
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948297
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948311
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948949
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948963
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948977
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949127
Principal investigator 1 Novo Nordisk AS $200.00 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949141
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949403
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949417
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949431
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949445
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949459
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949473
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949487
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208203
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208213
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208221
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208231
Principal investigator 1 Novo Nordisk AS $200.00 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208241
Principal investigator 1 Novo Nordisk AS $200.00 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208251
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208595
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208605
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208615
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208625
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208635
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208719
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208960
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208969
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208979
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208989
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739013
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739019
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739025
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739031
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739037
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739317
Principal investigator 1 Novo Nordisk AS $200.00 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739407
Principal investigator 1 Novo Nordisk AS $200.00 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739413
Principal investigator 1 Novo Nordisk AS $200.00 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739419
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739547
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739553
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739559
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739565
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739571
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739577
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739581
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739587
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805119
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805121
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805123
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805125
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805127
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805129
Principal investigator 1 Novo Nordisk AS $200.00 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805131
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805227
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805229
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805231
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805233
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805235
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805263
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805311
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805313
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805315
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805317
Principal investigator 1 Novo Nordisk AS $28.45 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811807701
Principal investigator 1 Novo Nordisk AS $24.95 07/12/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811807703
Principal investigator 1 Eli Lilly and Company $140,356.00 07/02/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO IN PARTICIPANTS WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES No dispute reported 06/30/2026 819465805
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948269
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948463
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948477
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948491
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948505
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948899
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948912
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948922
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948935
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949350
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949363
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949377
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949389
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208165
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208175
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208185
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208193
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208383
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208393
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208585
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208913
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208923
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208933
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208943
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208950
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811213535
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811738873
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811738879
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811738883
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811738995
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739001
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739007
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739143
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739149
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739155
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739311
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739537
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739543
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811744755
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805001
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805003
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805005
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805007
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805009
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805011
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805013
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805015
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805017
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805019
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805021
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805145
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805225
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805299
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805301
Principal investigator 1 Novo Nordisk AS $28.45 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805303
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805305
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805307
Principal investigator 1 Novo Nordisk AS $24.95 06/29/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805309
Principal investigator 1 Novo Nordisk AS $4,455.00 06/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208373
Principal investigator 1 Novo Nordisk AS $8,726.30 06/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739593
Principal investigator 1 Novo Nordisk AS $836.72 06/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767345
Principal investigator 1 Novo Nordisk AS $27.21 06/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948450
Principal investigator 1 Novo Nordisk AS $52.83 06/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208895
Principal investigator 1 Novo Nordisk AS $52.83 06/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208903
Principal investigator 1 Novo Nordisk AS $52.83 06/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739137
Principal investigator 1 Novo Nordisk AS $52.83 06/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739525
Principal investigator 1 Novo Nordisk AS $52.83 06/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739531
Principal investigator 1 Novo Nordisk AS $52.83 06/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805143
Principal investigator 1 Novo Nordisk AS $52.83 06/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805297
Principal investigator 1 Novo Nordisk AS $27.21 06/23/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208885
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2,100.00 06/17/2021 Non-covered Recipient Entity
TEXAS DIABETES & ENDOCRINOLOGY PA
PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM No dispute reported 06/30/2026 816734137
Principal investigator 1 Novo Nordisk AS $1,485.00 06/16/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811744761
Principal investigator 1 Novo Nordisk AS $1,485.00 06/16/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805295
Principal investigator 1 Novo Nordisk AS $27.21 06/11/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208575
Principal investigator 1 Novo Nordisk AS $27.21 06/11/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805223
Principal investigator 1 Novo Nordisk AS $23.06 05/28/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984298
Principal investigator 1 Novo Nordisk AS $1,000.00 05/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208999
Principal investigator 1 Novo Nordisk AS $2,500.00 05/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811738831
Principal investigator 1 Novo Nordisk AS $325.80 05/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739305
Principal investigator 1 Novo Nordisk AS $7.59 05/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767343
Principal investigator 1 Eli Lilly and Company $8,656.51 05/21/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY PA
A PHASE 2 STUDY OF ONCE-WEEKLY LY3437943 COMPARED WITH PLACEBO IN PARTICIPANTS WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT-RELATED COMORBIDITIES No dispute reported 06/30/2026 819465801
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948231
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948245
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948255
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948339
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948351
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948365
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948377
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948393
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948407
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948421
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948435
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948519
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948533
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948549
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948561
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948761
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948775
Principal investigator 1 Novo Nordisk AS $0.20 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948789
Principal investigator 1 Novo Nordisk AS $7.82 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948802
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948817
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948831
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948841
Principal investigator 1 Novo Nordisk AS $39.90 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948857
Principal investigator 1 Novo Nordisk AS $6.50 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948871
Principal investigator 1 Novo Nordisk AS $40.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948883
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949018
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949027
Principal investigator 1 Novo Nordisk AS $297.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949041
Principal investigator 1 Novo Nordisk AS $439.20 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949057
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949071
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949085
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949099
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949111
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949301
Principal investigator 1 Novo Nordisk AS $200.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949315
Principal investigator 1 Novo Nordisk AS $3.26 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949325
Principal investigator 1 Novo Nordisk AS $11.40 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949337
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208145
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208155
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208271
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208277
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208287
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208297
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208307
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208317
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208327
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208337
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208343
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208353
Principal investigator 1 Novo Nordisk AS $200.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208363
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208419
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208429
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208439
Principal investigator 1 Novo Nordisk AS $0.20 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208547
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208557
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208565
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208699
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208709
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208845
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208855
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208865
Principal investigator 1 Novo Nordisk AS $8.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208875
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811738843
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811738849
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811738855
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811738861
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811738867
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739055
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739061
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739067
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739073
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739079
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739085
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739091
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739097
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739103
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739109
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739113
Principal investigator 1 Novo Nordisk AS $200.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739119
Principal investigator 1 Novo Nordisk AS $200.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739125
Principal investigator 1 Novo Nordisk AS $200.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739131
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739293
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739299
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739371
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739377
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739383
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739389
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739395
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739401
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739495
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739501
Principal investigator 1 Novo Nordisk AS $200.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739507
Principal investigator 1 Novo Nordisk AS $200.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739513
Principal investigator 1 Novo Nordisk AS $2.92 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739519
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811804997
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811804999
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805133
Principal investigator 1 Novo Nordisk AS $4.99 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805135
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805137
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805139
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805141
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805217
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805219
Principal investigator 1 Novo Nordisk AS $9.74 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805221
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805247
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805249
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805251
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805253
Principal investigator 1 Novo Nordisk AS $28.45 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805255
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805257
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805259
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805261
Principal investigator 1 Novo Nordisk AS $15.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805289
Principal investigator 1 Novo Nordisk AS $19.00 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805291
Principal investigator 1 Novo Nordisk AS $0.64 05/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805293
Principal investigator 1 Novo Nordisk AS $11.73 05/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948189
Principal investigator 1 Novo Nordisk AS $488.70 05/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948201
Principal investigator 1 Novo Nordisk AS $658.80 05/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948215
Principal investigator 1 Novo Nordisk AS $0.30 05/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208125
Principal investigator 1 Novo Nordisk AS $0.30 05/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208135
Principal investigator 1 Novo Nordisk AS $1,485.00 05/03/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811738837
Principal investigator 1 Novo Nordisk AS $1.95 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948325
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948575
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948591
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948601
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948613
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948627
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810948991
Principal investigator 1 Novo Nordisk AS $4.38 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949005
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949153
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949165
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949179
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949191
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949205
Principal investigator 1 Novo Nordisk AS $0.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949219
Principal investigator 1 Novo Nordisk AS $59.85 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 810949233
Principal investigator 1 Novo Nordisk AS $1.95 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208261
Principal investigator 1 Novo Nordisk AS $1.95 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208401
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208409
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208448
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208457
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208467
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208477
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208487
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208497
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208645
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208653
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208663
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208671
Principal investigator 1 Novo Nordisk AS $4.89 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208681
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208729
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208739
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208749
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208759
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208769
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811208775
Principal investigator 1 Novo Nordisk AS $1.95 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739043
Principal investigator 1 Novo Nordisk AS $1.95 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739049
Principal investigator 1 Novo Nordisk AS $1.95 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739161
Principal investigator 1 Novo Nordisk AS $1.95 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739167
Principal investigator 1 Novo Nordisk AS $3.09 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739173
Principal investigator 1 Novo Nordisk AS $5.70 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739181
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739187
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739193
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739199
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739205
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739211
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739217
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739223
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739323
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739329
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739335
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739425
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739431
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739435
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739441
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739447
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739453
Principal investigator 1 Novo Nordisk AS $14.61 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739459
Principal investigator 1 Novo Nordisk AS $60.00 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739465
Principal investigator 1 Novo Nordisk AS $1.95 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805147
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805149
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805151
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805153
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805191
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805193
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805195
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805237
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805239
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805241
Principal investigator 1 Novo Nordisk AS $12.00 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805243
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805265
Principal investigator 1 Novo Nordisk AS $19.96 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805267
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805269
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805271
Principal investigator 1 Novo Nordisk AS $1.50 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805273
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805275
Principal investigator 1 Novo Nordisk AS $1.90 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805277
Principal investigator 1 Novo Nordisk AS $17.10 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805279
Principal investigator 1 Novo Nordisk AS $9.75 04/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811805281
Principal investigator 1 Novo Nordisk AS $844.31 04/23/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984471
Principal investigator 1 Novo Nordisk AS $23.06 04/14/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767319
Principal investigator 1 Novo Nordisk AS $3,206.79 04/04/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN1436-4625 No dispute reported 06/30/2026 811739229
Principal investigator 1 Novo Nordisk AS $617.07 03/24/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811817879
Principal investigator 1 Novo Nordisk AS $250.00 02/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 810984457
Principal investigator 1 Novo Nordisk AS $617.07 01/26/2021 Non-covered Recipient Entity
TEXAS DIABETES AND ENDOCRINOLOGY, PA
NN9535-4321 No dispute reported 06/30/2026 811767317